Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
188.86
+0.29 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,607,920
Open
188.97
Bid (Size)
187.69 (1)
Ask (Size)
190.66 (1)
Prev. Close
188.57
Today's Range
188.16 - 189.69
52wk Range
135.85 - 199.95
Shares Outstanding
N/A
Dividend Yield
3.13%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Growth Stocks That Could Be Bargain Buys Right Now
October 18, 2024
These stocks trade at less than 20 times their estimated future profits.
Via
The Motley Fool
FDA Approves AbbVie's Parkinson's Treatment, Medicare Coverage Expected Next Year
October 17, 2024
The FDA approved AbbVie's Vyalev as the first 24-hour subcutaneous infusion therapy for advanced Parkinson's disease, offering improved motor control and reduced symptoms. Approval was based on a...
Via
Benzinga
Exposures
Product Safety
Performance
YTD
+18.17%
+18.17%
1 Month
-2.46%
-2.46%
3 Month
+8.78%
+8.78%
6 Month
+12.49%
+12.49%
1 Year
+29.15%
+29.15%
More News
Read More
Market Analysis: AbbVie And Competitors In Biotechnology Industry
October 17, 2024
Via
Benzinga
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
October 17, 2024
Via
Benzinga
Looking Into AbbVie's Recent Short Interest
October 14, 2024
Via
Benzinga
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
October 14, 2024
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
October 10, 2024
Via
Benzinga
AbbVie's Options: A Look at What the Big Money is Thinking
October 09, 2024
Via
Benzinga
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
October 07, 2024
Via
Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
October 14, 2024
Via
The Motley Fool
Best Pharma Stocks for Long-Term Investors: Growth and Dividends
October 14, 2024
Via
MarketBeat
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
October 14, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Dividend Stock Analysis - Saturday, Oct. 12
October 12, 2024
Via
Talk Markets
There Are Only 28 S&P 500 Companies Warren Buffett Can't Buy Outright. Here's the Best of the Bunch for Income Investors.
October 12, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Comparing AbbVie With Industry Competitors In Biotechnology Industry
October 03, 2024
Via
Benzinga
AbbVie Stock Eyes New Highs: Analysts See Strong Growth Potential
October 11, 2024
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
Via
Benzinga
Biotech Stocks Poised For Another Big Move In Q4
October 07, 2024
Via
Talk Markets
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 07, 2024
Via
Benzinga
3 Magnificent Dividend Stocks to Buy in October
October 06, 2024
Via
The Motley Fool
Billionaires Are Loading Up on This High-Yield Dividend Stock. Should You?
October 06, 2024
Via
The Motley Fool
2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now
October 05, 2024
Via
The Motley Fool
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
October 04, 2024
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
3 Industries Set To Explode When Interest Rates Drop
October 03, 2024
Via
Talk Markets
Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal
October 03, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.